Phase I and pharmacological study of AZD1152, a selective inhibitor of aurora kinase B

Translated title of the contribution: Phase I and pharmacological study of AZD1152, a selective inhibitor of aurora kinase B

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Phase I and pharmacological study of AZD1152, a selective inhibitor of aurora kinase B
Original language	Undefined/Unknown
Pages (from-to)	782-783
Number of pages	2
Journal	British Journal of Clinical Pharmacology
Volume	68
Issue number	5
Publication status	Published - 2009

Cite this

@article{12efd553b78b43f8a9f3f03556eb8932,

title = "Phase I and pharmacological study of AZD1152, a selective inhibitor of aurora kinase B",

author = "D.S. Boss and P.O. Witteveen and M. Mergui and \{van der Sar\}, J. and P.K. Stockman and E.E. Voest and J.H. Beijnen and J.H.M. Schellens",

note = "ISI:000271626300024",

year = "2009",

language = "Undefined/Unknown",

volume = "68",

pages = "782--783",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "5",

}

TY - JOUR

T1 - Phase I and pharmacological study of AZD1152, a selective inhibitor of aurora kinase B

AU - Boss, D.S.

AU - Witteveen, P.O.

AU - Mergui, M.

AU - van der Sar, J.

AU - Stockman, P.K.

AU - Voest, E.E.

AU - Beijnen, J.H.

AU - Schellens, J.H.M.

N1 - ISI:000271626300024

PY - 2009

Y1 - 2009

M3 - Article

SN - 0306-5251

VL - 68

SP - 782

EP - 783

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

IS - 5

ER -